Literature DB >> 28083875

The role of oncoplastic breast reduction in the conservative management of breast cancer: Complications, survival, and quality of life.

Benigno Acea-Nebril1, Carmen Cereijo-Garea1, Alejandra García-Novoa1, Cristina Varela-Lamas1, Sergio Builes-Ramírez1, Alberto Bouzón-Alejandro1, Joaquín Mosquera-Oses1.   

Abstract

BACKGROUND AND OBJECTIVES: Reduction Mammaplasty (RM) in breast cancer allows mammary remodeling after wide excisions. We aimed to analyze the complications, survival, and quality of life after RM.
METHODS: Retrospective study of women who underwent a surgical intervention for breast cancer between 2000 and 2016. Patients were divided into two groups: RM and tumorectomy. Postoperative complications, survival and quality of life were assessed using the Breast-Q questionnaire.
RESULTS: A total of 801 patients were evaluated, with a mean follow up of 84 months. RM patients experienced a longer operating time and hospital stay, and a higher proportion of tissue necrosis compared to tumorectomy patients (P < 0.001). No significant differences were observed regarding rate of re-excision or rate of mastectomy, but the recurrence rate at 10 years was higher for RM patients (P < 0.03). Patients who underwent RM reported optimal satisfaction with the breast and a good quality of life.
CONCLUSIONS: RM is a useful approach in breast cancer surgery, with a low rate of re-excision and mastectomy. Overall survival at 10 years is similar to that associated with tumorectomy, though with a higher rate of local recurrence. Patient satisfaction and quality of life appears to be good one year after radiotherapy.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  breast-Q questionnaire; macromastia; multifocal/multicentric tumors

Mesh:

Year:  2017        PMID: 28083875     DOI: 10.1002/jso.24550

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  7 in total

1.  Visualized oncoplastic surgery of the breast I: inferior and medial quadrantectomy.

Authors:  Alberto Rancati; Claudio Angrigiani; Julio Dorr; Marcelo Irigo; Maurizio B Nava; Giuseppe Catanuto; Nicola Rocco; Agustin Rancati
Journal:  Gland Surg       Date:  2019-10

2.  Breast cancer patient-reported outcomes on level 1 and level 2 oncoplastic procedures using BREAST-Q®.

Authors:  C A Pinto; B Peleteiro; C S Pinto; F Osório; S Costa; A Magalhães; H Mora; J Amaral; D Gonçalves; J L Fougo
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-29       Impact factor: 4.322

Review 3.  Oncoplastic breast-conserving surgery for women with primary breast cancer.

Authors:  Akriti Nanda; Jesse Hu; Sarah Hodgkinson; Sanah Ali; Richard Rainsbury; Pankaj G Roy
Journal:  Cochrane Database Syst Rev       Date:  2021-10-29

4.  Oncoplastic surgery for the conservative treatment of breast cancer in Perú's National Cancer Institute.

Authors:  Gonzalo Javier Ziegler Rodriguez; Marcelo Diaz Chavez; Gabriela Guadalupe Calderon Valencia; Jose Manuel Cotrina Concha; Milko Raphael Garces Castre; Raul Mantilla
Journal:  Ecancermedicalscience       Date:  2018-03-01

5.  Patient-reported outcome after oncoplastic breast surgery compared with conventional breast-conserving surgery in breast cancer.

Authors:  Michael Rose; Henry Svensson; Jürgen Handler; Ute Hoyer; Anita Ringberg; Jonas Manjer
Journal:  Breast Cancer Res Treat       Date:  2020-01-27       Impact factor: 4.872

6.  Outcome reporting in therapeutic mammaplasty: a systematic review.

Authors:  Alice Lee; Richard M Kwasnicki; Hasaan Khan; Yasmin Grant; Abigail Chan; Angela E E Fanshawe; Daniel R Leff
Journal:  BJS Open       Date:  2021-11-09

7.  Oncoplastic Surgery in Breast-Conserving Treatment: Patient Profile and Impact on Quality of Life.

Authors:  Idam de Oliveira-Junior; Igor de Araujo da Silva; Fabíola Cristina Brandini da Silva; Jonathas José da Silva; Almir José Sarri; Carlos Eduardo Paiva; René Aloisio da Costa Vieira
Journal:  Breast Care (Basel)       Date:  2020-07-17       Impact factor: 2.268

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.